![](https://scx1.b-cdn.net/csz/news/tmb/2020/qolextendedw.jpg)
Quality of life extended with atezolizumab and bevacizumab in liver cancer
(HealthDay)—For patients with unresectable hepatocellular carcinoma, the combination of atezolizumab and bevacizumab is associated with longer time to deterioration of patient-reported quality of life (QOL); and decline ...
Jan 29, 2020
0
1